Abstract
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction [1, 2]. Mature CD4+ T-cells are involved in the production of these antibodies [3, 4]. The destruction at the neuromuscular endplates leads to the clinical symptom of muscle weakness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Drachman, D.B. 1994. Myasthenia gravis. N. Engl. J. Med. 330: 1797.
Oosterhuis, H.J. and J.B. Kuks. 1992. Myasthenia gravis and myasthenic syndromes. Curr. Opin. Neurol. Neurosurg. 5: 638.
Willcox, N. 1993. Myasthenia gravis. Curr. Opin. Immunol. 5: 910.
Vincent, A. 1994. Aetiological factors in development of myasthenia gravis. Adv. Neuroimmunol. 4: 355.
Marx, A., A. Wilisch, A. Schultz, S. Gattenlöhner, R. Nenninger and H. K. Müller-Hermelink. 1997. Pathogenesis of Myasthenia gravis. Virchows Archive 430: 355.
Müller-Hermelink, H.K., A. Wilisch, A. Schultz and A. Marx. 1997. Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma. Arch. of Hist. and Cyt. 60: 9.
Rosai, J. and G.D. Levine. 1976. Atlas of tumor pathology:Tumors of the thymus. Armed Forces Institute of Pathology, Washington
Meinl, E., W.E. Klinkert and H. Wekerle. 1991. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am. J. Pathol. 139: 995.
Marx, A., R. O’Connor, K.I. Geuder, F. Hoppe, B. Schalke, S. Tzartos, I. Kalies, T. Kirchner and H.K. Müller-Hermelink. 1990. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas [see comments]. Lab. Invest. 62: 279.
Marx, A., A. Wilisch, A. Schultz, A. Greiner, B. Magi, V. Pallini, B. Schalke, K. Toyka, W. Nix, T. Kirchner and H.K. Müller-Hermelink. 1996. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. Am. J. Pathol. 148: 1839.
Willcox, N., M. Schluep, M.A. Ritter, H.J. Schuurman, J. Newsom Davis and B. Christensson. 1987. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am. J. Pathol. 127: 447.
Takeuchi, Y., Y. Fujii, M. Okumura, K. Inada, K. Nakahara and H. Matsuda. 1993. Characterization of CD4+ single positive cells that lack CD3 in the human thymus. Cell Immunol. 151: 481.
Hohlfeld, R., K.V. Toyka, K. Heininger, H. Grosse Wilde, and I. Kalies. 1984. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 310: 244.
Sommer, N., G.C. Harcourt, N. Willcox, D. Beeson and J. Newsom Davis. 1991. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 41: 1270.
Müller, K.M. 1989. Anti-neuroblastoma antibodies in myasthenia gravis: clinical and immunological correlations. J. Neurol. Sci. 93: 263.
Marx, A., T. Kirchner, A. Greiner, H.K. Müller-Hermelink, B. Schalke and M. Osborn. 1992. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet. 339: 707.
Meager, A., A. Vincent, J. Newsom-Davis, and N. Willcox. 1997. Spontaneous neutralising antibodies to interferon—alpha and interleukin-12 in thymoma-associated autoimmune disease [letter]. Lancet. 350: 1596.
Müller-Hermelink, H.K., A. Marx and T. Kirchner. 1994. Advances in the diagnosis and classification of thymic epithelial tumors. In Recent Advances in Histopathology. P. Anthony and R. MacSween, eds. Edinburgh, Churchill Livingstone, p. 49.
Nenninger, R., A. Schultz, V. Hoffacker, M. Helmreich, A. Wilisch, B. Vandekerckhove, T. Hunig, B. Schalke, C. Schneider, S. Tzartos, H. Kaibacher, H.K. Muller-Hermelink and A. Marx. 1998. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab. Invest. 78: 743.
Myers, M.W., R.A. Lazzarini, V.M. Lee, W.W. Schlaepfer and D.L. Nelson. 1987. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J. 6: 1617.
Sommer, N., N. Willcox, G.C. Harcourt and J. Newsom Davis. 1990. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann. Neurol. 28: 312.
Tzartos, S.J. and M.S. Remoundos. 1992. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope. Eur. J. Biochem. 207: 915.
Vanhecke, D., G. Leclercq, J. Plum and B. Vandekerckhove. 1995. Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J. Immunol. 155: 1862.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hoffacker, V., Schultz, A., Nenninger, R., Tzartos, S., Müller-Hermelink, HK., Marx, A. (2000). Abnormal Thymocyte Development and Neurofilament-Reactive Thymocytes in Thymoma. In: Christadoss, P. (eds) Myasthenia Gravis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4060-7_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-4060-7_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5787-5
Online ISBN: 978-94-011-4060-7
eBook Packages: Springer Book Archive